FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3003257544> ?p ?o ?g. }

• W3003257544 abstract "Abstract Osteoarthritis (OA) is a debilitating and prevalent chronic disease, but there are no approved disease modifying OA drugs (DMOADs), only pharmaceuticals for pain management. OA progression, particularly for post-traumatic osteoarthritis (PTOA), is associated with inflammation and enzymatic degradation of the extracellular matrix. In particular, Matrix Metalloproteinase 13 (MMP13) breaks down collagen type 2 (CII), a key structural component of cartilage extracellular matrix, and consequently, matrix degradation fragments perpetuate inflammation and a degenerative cycle that leads to progressive joint pathology. Here, we tested targeted delivery of endosome-escaping, MMP13 RNA interference (RNAi) nanoparticles (NPs) as a DMOAD. The new targeting approach pursued here deviates from the convention of targeting specific cell types ( e.g ., through cell surface receptors) and instead leverages a monoclonal antibody (mAbCII) that targets extracellular CII that becomes uniquely accessible at early OA focal defects. Targeted mAbCII-siNPs create an in situ NP depot for retention and potent activity within OA joints. The mAbCII-siNPs loaded with MMP13 siRNA (mAbCII-siNP/siMMP13) potently suppressed MMP13 expression (95% silencing) in TNFα-stimulated chondrocytes in vitro , and the targeted mAbCII-siNPs had higher binding to trypsin-damaged porcine cartilage than untargeted control NPs. In an acute mechanical injury mouse model of PTOA, mAbCII-siNP/siMMP13 achieved 80% reduction in MMP13 expression (p = 0.00231), whereas a non-targeted control achieved only 55% silencing. In a more severe, PTOA model, weekly mAbCII-siNP/siMMP13 long-term treatment provided significant protection of cartilage integrity (0.45+/− .3 vs 1.6+/−.5 on the OARSI scale; p=0.0166), and overall joint structure (1.3+/−.6 vs 2.8+/−.2 on the Degenerative Joint Disease scale; p<0.05). Intra-articular mAbCII-siNPs better protected articular cartilage (OARSI score) relative to either single or weekly treatment with the clinical gold stand steroid treatment methylprednisolone. Finally, multiplexed gene expression analysis of 254 inflammation-related genes showed that MMP13 inhibition suppressed clusters of genes associated with tissue restructuring, angiogenesis (associated with synovial inflammation and thickening), innate immune response, and proteolysis. This work establishes the new concept of targeting unique local extracellular matrix signatures to sustain retention and increase delivery efficacy of biologics with intracellular activity and also validates the promise of MMP13 RNAi as a DMOAD in a clinically-relevant therapeutic context. Abstract Figure: PTOA targeted delivery of MMP13 siRNA to block disease progression The top left schematic illustrates the progression (left to right) from healthy knee joint, through inflammation induction following traumatic injury, to cartilage loss and degenerative joint disease (including synovial response). Degradation of cartilage enhances inflammation, inducing a degenerative cycle (middle right). The bottom of the graphic illustrates the concept of the matrix targeted nanocarriers for enhanced retention and activity of MMP13 siRNA at sites of cartilage injury." @default.
• W3003257544 created "2020-02-07" @default.
• W3003257544 creator A5001345876 @default.
• W3003257544 creator A5004975742 @default.
• W3003257544 creator A5010321830 @default.
• W3003257544 creator A5033113635 @default.
• W3003257544 creator A5036590387 @default.
• W3003257544 creator A5045060680 @default.
• W3003257544 creator A5047889496 @default.
• W3003257544 creator A5050051218 @default.
• W3003257544 creator A5058747742 @default.
• W3003257544 creator A5061624427 @default.
• W3003257544 date "2020-01-31" @default.
• W3003257544 modified "2023-10-11" @default.
• W3003257544 title "Matrix-targeted Nanoparticles for MMP13 RNA Interference Blocks Post-Traumatic Osteoarthritis" @default.
• W3003257544 cites W1227988319 @default.
• W3003257544 cites W1488574137 @default.
• W3003257544 cites W1533739166 @default.
• W3003257544 cites W1975890825 @default.
• W3003257544 cites W1975916494 @default.
• W3003257544 cites W1977479530 @default.
• W3003257544 cites W1980432870 @default.
• W3003257544 cites W1985842679 @default.
• W3003257544 cites W1993523958 @default.
• W3003257544 cites W2001775655 @default.
• W3003257544 cites W2002387722 @default.
• W3003257544 cites W2007347651 @default.
• W3003257544 cites W2021862408 @default.
• W3003257544 cites W2022481046 @default.
• W3003257544 cites W2022991367 @default.
• W3003257544 cites W2025086334 @default.
• W3003257544 cites W2028964241 @default.
• W3003257544 cites W2030554406 @default.
• W3003257544 cites W2030919384 @default.
• W3003257544 cites W2035709831 @default.
• W3003257544 cites W2035972979 @default.
• W3003257544 cites W2036179692 @default.
• W3003257544 cites W2048053833 @default.
• W3003257544 cites W2049407173 @default.
• W3003257544 cites W2052643851 @default.
• W3003257544 cites W2058894658 @default.
• W3003257544 cites W2072589601 @default.
• W3003257544 cites W2076844194 @default.
• W3003257544 cites W2077640938 @default.
• W3003257544 cites W2082893787 @default.
• W3003257544 cites W2085788584 @default.
• W3003257544 cites W2086349374 @default.
• W3003257544 cites W2089293788 @default.
• W3003257544 cites W2091921078 @default.
• W3003257544 cites W2101013580 @default.
• W3003257544 cites W2106582491 @default.
• W3003257544 cites W2117099303 @default.
• W3003257544 cites W2127878636 @default.
• W3003257544 cites W2135245708 @default.
• W3003257544 cites W2136038462 @default.
• W3003257544 cites W2157715043 @default.
• W3003257544 cites W2161736885 @default.
• W3003257544 cites W2161935632 @default.
• W3003257544 cites W2163083170 @default.
• W3003257544 cites W2164531777 @default.
• W3003257544 cites W2164893191 @default.
• W3003257544 cites W2172129201 @default.
• W3003257544 cites W2267377424 @default.
• W3003257544 cites W2298017854 @default.
• W3003257544 cites W2337825062 @default.
• W3003257544 cites W2340662778 @default.
• W3003257544 cites W2417409910 @default.
• W3003257544 cites W2591992124 @default.
• W3003257544 cites W2599900557 @default.
• W3003257544 cites W2600319591 @default.
• W3003257544 cites W2605118946 @default.
• W3003257544 cites W2612434055 @default.
• W3003257544 cites W2616167388 @default.
• W3003257544 cites W2616789213 @default.
• W3003257544 cites W2617012077 @default.
• W3003257544 cites W2751089619 @default.
• W3003257544 cites W2752521947 @default.
• W3003257544 cites W2761316764 @default.
• W3003257544 cites W2777909748 @default.
• W3003257544 cites W2781977511 @default.
• W3003257544 cites W2792383110 @default.
• W3003257544 cites W2893168313 @default.
• W3003257544 cites W2899904097 @default.
• W3003257544 cites W2910221008 @default.
• W3003257544 cites W2986392478 @default.
• W3003257544 cites W2994359976 @default.
• W3003257544 cites W3000734109 @default.
• W3003257544 cites W4231737923 @default.
• W3003257544 cites W4232024554 @default.
• W3003257544 doi "https://doi.org/10.1101/2020.01.30.925321" @default.
• W3003257544 hasPublicationYear "2020" @default.
• W3003257544 type Work @default.
• W3003257544 sameAs 3003257544 @default.
• W3003257544 citedByCount "4" @default.
• W3003257544 countsByYear W30032575442020 @default.
• W3003257544 countsByYear W30032575442021 @default.
• W3003257544 countsByYear W30032575442022 @default.
• W3003257544 countsByYear W30032575442023 @default.
• W3003257544 crossrefType "posted-content" @default.
• W3003257544 hasAuthorship W3003257544A5001345876 @default.

• next